John J. Orloff
Currently, John J. Orloff occupies the position of Executive VP, Head-Research & Development at Alexion Pharmaceuticals, Inc.
In the past Dr. Orloff occupied the position of Director at Novelion Therapeutics, Inc., Chief Scientific Officer, EVP, Global Head-R&D at Baxalta, Inc., Vice President, Global Head-Research & Development at Baxter BioScience Corp., Chief Medical Officer & Senior Vice President for Novartis Pharma AG and Executive Vice President & Head-Research at Aegerion Pharmaceuticals, Inc.
John J. Orloff received an undergraduate degree from Dartmouth College and a doctorate from the University of Vermont College of Medicine.
|12/16/2020||3,261||Derivative/Non-derivative trans. at $157.96 per share.||515,108|
|12/16/2020||18,134||Derivative/Non-derivative trans. at $157.96 per share.||2,864,447|
|12/16/2020||40,677||Award at $0 per share.||0|
|12/15/2020||40||Award at $93.53 per share.||3,741|
|06/08/2020||2,784||Derivative/Non-derivative trans. at $114.61 per share.||319,075|
|03/02/2020||1,396||Derivative/Non-derivative trans. at $90.54 per share.||126,394|
|02/28/2020||10,880||Award at $0 per share.||0|
|12/15/2019||38||Award at $93.86 per share.||3,566|
|06/07/2019||2,786||Derivative/Non-derivative trans. at $118.61 per share.||330,448|
|02/28/2019||9,428||Award at $0 per share.||0|
|02/28/2019||675||Derivative/Non-derivative trans. at $132.92 per share.||89,721|
|12/15/2018||34||Award at $93.01 per share.||3,162|
|06/08/2018||2,115||Disposition at $118.53 per share.||250,691|
|02/28/2018||8,940||Award at $0 per share.||0|
|06/07/2017||24,965||Award at $0 per share.||0|